First described 60 years ago, Castleman disease comprises a rare and heterogeneous
cluster of disorders, characterized by lymphadenopathy with unique histological features …

This study retrospectively collected the clinical and laboratory data of 114 patients with
Castleman disease (CD) from a single medical centre. Clinical classification identified 62 …

Castleman's disease is not just a single disease but rather an uncommon, heterogeneous
group of nonclonal lymphoproliferative disorders, which have a broad spectrum of clinical …

Angiofollicular lymph node hyperplasia, with the eponym Castleman disease (CD) is a
histomorphologic entity uniting a group of diseases with related and occasionally …

Background Castleman disease (CD) is a rare polyclonal lymphoproliferative disorder with
unknown etiology. TAFRO syndrome is now regarded as a specific subtype of CD, and is still …

POEMS (polyneuropathy, organomegaly, endocrinopathy monoclonal gammopathy, and
skin changes) syndrome is occasionally associated with Castleman disease (CD) and their …

La enfermedad de Castleman no es una única enfermedad. Bajo este epónimo se reúne un
heterogéneo grupo de trastornos linfoproliferativos no clonales, muy infrecuentes, con un …

Castleman disease (CD) is uncommon non-clonal lymphoproliferative disorder with
unknown etiology. No standard therapy is recommended for relapsed/refractory CD patients …

Interventions: She was treated with combination of tocilizumab, lenalidomide, and
glucocorticoids. Outcomes: This patient achieved complete remission (CR) with all her …

一线治疗失败或复发的老年多中心型Castleman 病(MCD) 患者尚无标准的治疗方案,
国外文献报道来那度胺对于复发/难治的MCD 有一定疗效, 但中文文献报道较少. 本文报道2 …